By Ayumi Takano, Kunihiko Takahashi, Tatsuhiko Anzai, Takashi Usami, Shiori Tsutsumi, Yuka Kanazawa, Yousuke Kumakura, Toshihiko Matsumoto

Background: Methamphetamine use is related to severe health, social, and criminal challenges. However, there is limited evidence regarding the factors associated with the recurrence of drug use among individuals who have used methamphetamine, particularly within populations involved in the criminal justice system. This study aimed to identify predictors of illicit drug use at a one-year follow-up among males in Japan who have used methamphetamine and are involved in the criminal justice system.

Methods: The study participants were adult males on probation due to methamphetamine use or possession and were involved in a community-based program. The participants were recruited early in their probation period and participated in telephone-based surveys conducted by mental health center staff. We analyzed one-year follow-up data to investigate the recurrence rate of illicit drug use and associated risk factors using multiple logistic regression.

Results: Out of 234 participants, 27 (11.5 %) used illicit drugs during the one-year follow-up period. After adjusting for demographic characteristics, severity of drug use, type of probation, and use of treatment for substance use disorders, the use of social welfare services (OR = 2.78) and a lack of trustworthy relationships (OR = 3.17) were significantly associated with recurrence of illicit drug use.

Conclusions: This study suggested that individuals facing challenges in maintaining stable living conditions and building trustworthy relationships were more likely to return to drug use early in their probation period. Comprehensive and tailored support focused on social stabilization and relationship-building is recommended to aid recovery in males who have experienced methamphetamine use.

Drug and Alcohol Dependence Reports, Volume 14, March 2025, 100316

By Mardet Homans, Denise M. Allen & Yesenia Mazariegos

The use of Medication Assisted Treatment (MAT), and specifically buprenorphine, to address opioid use disorder (OUD) is considered the gold standard of care in the community (Substance Abuse and Mental Health Service Administration (SAMHSA), 2023). However, while support of its use in correctional settings is expanding, and there are national promising practice guidelines, it remains underutilized within jails and prisons in the United States (U.S.) (National Commission on Correctional Healthcare (NCCHC), 2018; Friedmann et al., 2012). The efficacy of MAT to reduce opiate withdrawal, curb cravings, and support positive health, behavioral health, and criminal justice outcomes, including reductions in overdose deaths and recidivism, has gained national attention from criminal justice advocacy groups and policymakers. Jails and correctional agencies have been taken to court over the provision of MAT for incarcerated individuals with OUD. And state and federal courts have ruled denial of MAT for incarcerated individuals with OUD violates the Americans with Disabilities Act (ADA) (Legislative Analysis and Public Policy Association (LAPPA), n.d.). The California Department of Corrections and Rehabilitation (CDCR) and California Correctional Health Care Services (CCHCS) are at the forefront of providing MAT in a correctional setting under the Integrated Substance Use Disorder Treatment (ISUDT) Program. The ISUDT Program begins at intake into CDCR with a substance use disorder (SUD) screening and assessment and linkage to behavioral interventions and MAT with a targeted focus on preparing CDCR residents for release. This paper seeks to document the provision of MAT in correctional settings since it is expanding rapidly within the U.S. and there is currently not a national inventory of programs or practices. In addition, this paper aims to document best practices and lessons learned from California and other correctional systems that can be used to guide expansion of MAT to justice-involved populations. Contained in the appendix of this report is a comprehensive review of information regarding the current availability of MAT in U.S. jails and prisons.

Key Findings • According to the Bureau of Justice Statistics (BJS) less than 1% of the Federal Bureau of Prisons (BOP) population received MAT in 2021. • Based on a review of publicly available information, it does appear that five states – Alabama, Mississippi, Nebraska, South Dakota, and Wyoming offer MAT in their correctional institutions. • A number of states have or are currently piloting MAT in corrections. • Besides California, only 14 states offer comprehensive MAT services at either intake and/or release in a considerable number of its jails and prisons. • Locating details regarding MAT provision on many state and local correctional websites is difficult or is missing altogether. This may present as a barrier to SUD treatment and discourage justice-involved individuals or their families from seeking MAT. • Overall, there is significant variability among states regarding the provision of MAT to incarcerated individuals.

Irvine, CA: Center for Evidence‐Based Corrections University of California, Irvine 2023. 18p.